share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  05/31 17:05

Moomoo AI 已提取核心訊息

On May 28, 2024, Conduit Pharmaceuticals Inc. received a notice from The Nasdaq Stock Market LLC indicating that the company is not in compliance with Nasdaq's independent audit committee requirements. This non-compliance occurred following the resignation of Ms. Jennifer McNealey from the Board and all committees, leaving the audit committee with only two independent directors. The company has been given until the earlier of its next annual shareholders' meeting or May 13, 2025, to regain compliance, with an extended deadline of November 12, 2024, if the annual meeting occurs before that date. The notice does not affect the current listing of the company's securities on Nasdaq. Conduit Pharmaceuticals plans to address the issue by appointing at least one more independent director to the audit committee within the given timeframe.
On May 28, 2024, Conduit Pharmaceuticals Inc. received a notice from The Nasdaq Stock Market LLC indicating that the company is not in compliance with Nasdaq's independent audit committee requirements. This non-compliance occurred following the resignation of Ms. Jennifer McNealey from the Board and all committees, leaving the audit committee with only two independent directors. The company has been given until the earlier of its next annual shareholders' meeting or May 13, 2025, to regain compliance, with an extended deadline of November 12, 2024, if the annual meeting occurs before that date. The notice does not affect the current listing of the company's securities on Nasdaq. Conduit Pharmaceuticals plans to address the issue by appointing at least one more independent director to the audit committee within the given timeframe.
2024年5月28日,Conduit Pharmicals Inc.收到納斯達克股票市場有限責任公司的通知,表明該公司沒有遵守納斯達克獨立審計委員會的要求。這種違規行爲發生在詹妮弗·麥克尼利女士辭去董事會和所有委員會的職務後,審計委員會只有兩名獨立董事。該公司有權在下一次年度股東大會的較早者或2025年5月13日之前恢復合規,如果年會在此日期之前舉行,則將截止日期延長至2024年11月12日。該通知不影響該公司證券目前在納斯達克的上市。Conduit Pharmicals計劃通過在給定的時間範圍內至少再任命一名獨立董事加入審計委員會來解決這個問題。
2024年5月28日,Conduit Pharmicals Inc.收到納斯達克股票市場有限責任公司的通知,表明該公司沒有遵守納斯達克獨立審計委員會的要求。這種違規行爲發生在詹妮弗·麥克尼利女士辭去董事會和所有委員會的職務後,審計委員會只有兩名獨立董事。該公司有權在下一次年度股東大會的較早者或2025年5月13日之前恢復合規,如果年會在此日期之前舉行,則將截止日期延長至2024年11月12日。該通知不影響該公司證券目前在納斯達克的上市。Conduit Pharmicals計劃通過在給定的時間範圍內至少再任命一名獨立董事加入審計委員會來解決這個問題。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息